Diverticular Disease and Rifaximin: An Evidence-Based Review
Diverticular Disease and Rifaximin: An Evidence-Based Review
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
There have been considerable advances in the treatment of diverticular disease in recent years. Antibiotics are frequently used to treat symptoms and prevent complications. Rifaximin, a non-absorbable antibiotic, is a common therapeutic choice for symptomatic diverticular disease in various countries, including Italy. Because of its low systemic ab...
Alternative Titles
Full title
Diverticular Disease and Rifaximin: An Evidence-Based Review
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_665c7c6aa34848f9b199f770801380a8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_665c7c6aa34848f9b199f770801380a8
Other Identifiers
ISSN
2079-6382
E-ISSN
2079-6382
DOI
10.3390/antibiotics12030443
